Compare SoundHound AI Inc (SOUN) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SoundHound AI Inc vs TransMedics Group Inc — how do they compare? SoundHound AI Inc trades at $6.55 (market cap $2.75B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: SoundHound AI Inc and TransMedics Group Inc are close in size by market cap. Which is the better fit depends on your goals.
| SOUN | TMDX | |
|---|---|---|
Market Cap | $2.75B | $2.54B |
Sector | Technology | Technology |
52-Week High | $21.40 | $150.42 |
52-Week Low | $5.90 | $61.99 |
Enterprise Value | $2.54B | $2.94B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SoundHound AI Inc
SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
